These benefits are primarily mediated through activation of BDNF-TrkB signaling, leading to reduced ROS/H<sub>2</sub>O<sub>2</sub> accumulation and alleviation of CRS-induced depression-like behaviors. The gene discussed is NTRK2; the disease is depressive disorder.